(Q21563446)

13 November 2016

title

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib (English)

1 reference

13 November 2016

1 reference

10

Harold E Varmus

Harold E

Varmus

1 reference

2 September 2022

1

William Pao

William

Pao

1 reference

2 September 2022

6

Marc Ladanyi

Marc

Ladanyi

1 reference

2 September 2022

9

Mark G Kris

Mark G

Kris

1 reference

2 September 2022

3

Gregory J

Riely

Gregory J Riely

1 reference

2 September 2022

5

Qiulu

Pan

Qiulu Pan

1 reference

2 September 2022

7

Maureen F

Zakowski

Maureen F Zakowski

1 reference

2 September 2022

8

Robert T

Heelan

Robert T Heelan

1 reference

2 September 2022

Theresa Y Wang

2

Theresa Y

Wang

1 reference

2 September 2022

Vincent A Miller

series ordinal

4

author given names

Vincent A

author last names

Miller

1 reference

Creative Commons Attribution 4.0 International

2 September 2022

language of work or name

English

0 references

publication date

January 2005

0 references

published in

PLOS MEDICINE

0 references

volume

2

0 references

issue

1

0 references

page(s)

e17

0 references

copyright license

start time

25 January 2005

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Lung cancer: intragenic ERBB2 kinase mutations in tumours

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

The ras oncogenes in human lung cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=545207

Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung

30 May 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/15696205

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15696205

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PMED.0020017

1 reference

1 reference

1 reference

1 reference